2 assets in Hereditary Thrombophilia Due To Congenital Protein C Deficiency

Therapeutic assets addressing Hereditary Thrombophilia Due To Congenital Protein C Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Hwk-007 Hereditary Thrombophilia Due To Congenital Protein C Deficiency	Whitehawk Therapeutics, Inc.	P1	CC (43)
Hwk-016, Mucin-16-Targeted Adc Hereditary Thrombophilia Due To Congenital Protein C Deficiency	Whitehawk Therapeutics, Inc.	P1	CC (43)